Which Weight Loss Drug Has Less Side Effects? (October 2026)

01 · The short version

So which weight loss drug has fewer side effects?

The honest answer is that nobody can responsibly name a single weight loss drug with fewer side effects for everyone. The licensed injectable medicines work on gut hormones, and the effects people notice, such as nausea, a change in bowel habit and feeling full quickly, come from that same action. A drug that is easy for one person can be hard for another, and the dose you reach matters as much as the brand.

What we can do is tell you what is known about Mounjaro, which we supply.

If you want a direct side-by-side of two named products, our guides on Wegovy or Mounjaro side effects and Ozempic or Mounjaro side effects go through the question one pair at a time.

02 · Why no league table

Why a fair ranking is so hard

Side-effect comparisons between medicines are only meaningful when the same kind of people take them, for the same length of time, at comparable doses, and are asked the same questions. Separate trials rarely line up that neatly.

03 · Your next step

What to do if tolerability is your main worry

Start by treating tolerability as something you manage with a prescriber rather than something you buy by choosing a brand. Mounjaro begins at the lowest strength, 2.5mg, and after at least 4 weeks on each dose can step up through 5mg, 7.5mg, 10mg and 12.5mg to a maximum of 15mg, depending on how you respond; if a new dose is hard to tolerate, prescribers can hold the current dose longer before stepping up.¹

If you are weighing up treatment, our free online consultation is reviewed by a GPhC-registered prescriber, who can discuss your history and which medicine and pace suit you. Our weight loss clinic page explains the wider service, including ongoing monthly reviews and side-effect support.

For a fuller view of the medicine we supply, read our Mounjaro side effects guide. If you are comparing several options for comfort specifically, weight loss injections with fewer side effects covers that angle in more depth.

04 · Why side effects occur

Why weight loss drugs cause side effects at all

Weight loss medicines of this class work by acting on the body's own appetite and digestion signals, so their benefits and their side effects come from the same place. Understanding that helps explain why asking for a drug with no side effects is a little like asking for a painkiller that never affects the body.

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly.¹ Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. That slower stomach emptying is also the reason many of the common effects are digestive. Food sits for longer, so nausea, reflux, burping, constipation or a feeling of heaviness after a meal can follow, particularly if the meal is large or rich.

This does not mean side effects are the price you must pay for results. It means they are a predictable consequence of how the medicine behaves, and predictable things can be planned around. Dose pace, meal size, hydration and fibre all influence how noticeable the effects are.

It also explains why we are cautious about claims that one product is gentle and another harsh. Medicines that act on the same gut signals tend to share the same type of effect. Differences between them, where they exist, usually show up in how often and how strongly effects occur, and those differences depend on dose, trial design and the people studied rather than on a simple good-or-bad label.

The medicine can also affect other things you take. Because stomach emptying slows, it can reduce how well oral contraceptive pills are absorbed. The advice is to switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. Insulin and sulfonylureas may also need their doses reviewed, because low blood sugar is a risk when they are combined with Mounjaro. None of this is a reason to avoid treatment, but it is a reason to answer every question in the consultation fully.

The patient leaflet that comes with each pen sets out every listed effect in plain language.¹³ Read it before your first injection, and keep it to hand when you move up a dose. If you notice something new that is not described there, tell your prescriber and consider reporting it through the Yellow Card scheme.¹⁹

05 · Common effects overview

The most common Mounjaro side effects

Mounjaro's common side effects are mostly digestive, and they follow a recognisable pattern. Like all medicines, Mounjaro can cause side effects, and most are digestive.¹

The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹

Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions.¹

Notice what the list does and does not tell you. It tells you which effects to expect and roughly how often they occur. It does not tell you that you will have them, or that they will be severe. Many people notice only mild nausea for a short time, and some barely notice any effect at all.

Equally, the list is not a ranking against other drugs. If you read that a different medicine has a shorter list, check whether that list is shorter because the medicine is gentler or because less data has been gathered, the trial was smaller, or the effects were recorded differently. A short list is not automatically a safer one.

Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.¹ That timing is the most useful thing to know. If you feel unwell in the days after an injection or a dose increase, that is the expected window, and it usually passes.

Think of side effects in three tiers. The first is the everyday digestive group, which most people can manage with food and fluid changes. The second is the quality-of-life group, such as tiredness, hair shedding or skin reactions, which are usually temporary or manageable. The third is the uncommon serious group, such as pancreatitis, gallbladder problems or allergic reaction, which need urgent medical help.

Knowing which tier a symptom belongs to is half the battle. It stops people stopping a medicine they are benefiting from over something mild, and it stops them ignoring something that needs attention. When in doubt, contact your clinical team; our ongoing monthly reviews exist so that you are not guessing alone.

For a longer walk-through of each effect, our Mounjaro side effects guide sets them out one by one.

06 · Trial stomach rates

What the weight-management trials recorded

The trials behind Mounjaro's weight-management licence recorded stomach effects by dose, which lets you see how they scale. These figures describe one medicine only; they should not be set against another medicine's trial numbers as though the studies were identical.

In the trials supporting Mounjaro's weight-management licence, nausea was reported by 24.6% of people on 5mg, 29.0% on 10mg and 28.0% on 15mg, compared with 8.5% on placebo.¹

Diarrhoea was reported by 18.7% of people on 5mg, 20.8% on 10mg and 22.5% on 15mg, compared with 7.8% on placebo.¹

Nausea, vomiting and diarrhoea were more common while the dose was being increased and became less frequent over time.¹

1.9% of people on 5mg, 3.3% on 10mg and 4.3% on 15mg stopped treatment permanently because of gastrointestinal side effects, compared with 0.5% on placebo.¹

First, the effects were higher than placebo at every dose, which confirms they are treatment-related rather than coincidence. Second, the proportion who stopped permanently because of stomach effects was small at every dose, which suggests most people who experience them find them manageable.

In SURMOUNT-1, 4.3% of people on 5mg, 7.1% on 10mg and 6.2% on 15mg stopped treatment because of side effects, compared with 2.6% on placebo.² Importantly, the large majority continued, and a small group on placebo also stopped, a reminder that any injection regime comes with some drop-out for all sorts of reasons.

What these numbers cannot tell you is how you personally will respond. Trial averages do not predict your own result, and individual results vary. Use them to set expectations, not to forecast.

07 · Timeline and dose ladder

When side effects appear and how the dose ladder helps

Side effects follow a timeline, and knowing it is the single most reassuring thing for a new patient. Most side effects follow a pattern: they appear in the first days after starting or increasing a dose, peak early, and settle as your body adapts.¹

This is one reason Mounjaro uses a gradual dose ladder.¹ Rather than starting at the full strength, treatment begins at 2.5mg and steps through 5mg, 7.5mg, 10mg, 12.5mg and 15mg.

The ladder is not just paperwork. It lets your gut and appetite signals adjust gradually, so each step is a small change from the one before. In effect, the dose ladder is the main built-in tolerability tool.

If a new dose is hard to tolerate, prescribers can hold the current dose longer before stepping up — speak to your clinical team rather than pushing through severe symptoms.¹ This matters because it means a difficult step does not force you to quit. You can stay at the strength that is working, and move on only when you feel ready.

A practical way to plan the first months is to expect the least comfortable days to fall shortly after each injection and especially after each increase, and to schedule heavier commitments away from those days where you can. Keep simple, plain food available. Many people find that eating lightly in the day or two after the injection makes a real difference.

Do not assume that because one step was easy the next will be, or that because one step was hard they all will be. Tolerability is often uneven. Keep a simple note, or use the free GLPTrackr companion app, to record how you feel after each dose. Those notes make your monthly review far more useful, because your prescriber can see the pattern rather than relying on memory.

If you stop Mounjaro, remember that tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears. If side effects are the reason you are stopping, expect them to fade over that period rather than vanish overnight.

What you should not do is adjust doses yourself, split pens or stretch them; this is unlicensed. Changes to your schedule belong with your prescriber, who knows your history and can make them safely.

08 · Easing digestive effects

Practical ways to ease nausea and constipation

The most effective tolerability tools are practical habits, and they work with any dose. Those habits are simple: eat smaller meals slowly, stop at the first feeling of fullness, favour plain lower-fat foods while adjusting, stay well hydrated, and avoid lying down straight after eating.¹

Each of these answers a specific problem. Smaller meals respect the slower stomach emptying. Stopping at fullness helps avoid feeling overfilled. Plain, lower-fat food is easier to digest while the body adapts. Staying upright after eating helps with reflux and burping.

If nausea or vomiting is persistent or you cannot keep fluids down, contact your clinical team — dehydration needs prompt attention.¹ This is the one situation where waiting it out is not the right approach.

Constipation deserves its own attention because it is common and easy to under-manage. Constipation is very common on Mounjaro for weight management (it may affect more than 1 in 10 people), because food moves through the gut more slowly and many people eat and drink less.¹

What helps: fluid intake first, then fibre from vegetables and whole grains, and daily movement.

If constipation persists, a pharmacist can recommend a suitable laxative. Contact your clinical team for pain, bloating or more than a few days without a bowel movement.¹ Do not wait several uncomfortable days before asking; this is a very ordinary problem and the team has heard it many times.

Diarrhoea, the opposite problem, is also listed among the most common effects. The same general approach applies: keep up fluids, choose plain foods, and tell your team if it is severe or does not settle, since fluid loss can add up quickly.

Notice that none of these steps involve changing medicine. If, after sensible adjustments, a dose is still hard to bear, talk to your prescriber about holding the dose.

Our guide to the weight loss drug with the least side effects adds more everyday tips on this theme.

09 · Hair, energy, skin and face

Hair shedding, tiredness, injection sites and facial changes

Several side effects are not stomach-related but are worth knowing about, because they often cause more worry than they deserve. The first is hair. Temporary hair shedding is a recognised side effect, reported as common in trials and linked to rapid weight loss itself rather than a direct drug effect.¹ For most people it settles as weight stabilises. Hair loss was reported by 4.9% of people taking tirzepatide in the weight-management trials, compared with 1.0% on placebo.¹ Protein intake and overall nutrition matter — another reason the reduced-calorie diet should stay balanced.

Next is tiredness. Fatigue is a recognised common side effect, most noticeable in the first weeks and after dose increases. It usually reflects a mix of the body adjusting and simply eating less — so keep meals balanced (protein especially), stay hydrated, and keep gentle activity going. For most people energy returns to normal within a few weeks; tell your clinical team if tiredness is severe or not settling.

Injection sites are the third area. Injection-site reactions were reported by 8.0% of people taking tirzepatide in the weight-management trials, compared with 1.8% on placebo.¹ Mild redness, itching, a small bruise or a tender lump at the injection site is common and normally settles within a few days. Rotating sites each week and letting the pen warm briefly out of the fridge reduces stinging. Contact your clinical team if a reaction is spreading, hot, very painful, or lasts more than a week.

Finally, the face and skin. "Ozempic face" is not a drug effect — it is what losing a significant amount of weight quickly can do to facial volume, on any method including diet or surgery. The same applies to loose skin. The counter-measures are the ones that protect lean mass: adequate protein, resistance exercise, and a loss pace guided by your prescriber rather than maximum speed. Skin commonly adapts gradually after weight stabilises.

These four examples share a theme. Several of them are consequences of losing weight, or of eating less, rather than of the medicine as such.

It also means that supporting your body during weight loss, with enough protein, balanced meals, strength work and fluid, is a tolerability strategy in its own right. Ask your prescriber to guide the pace rather than aiming for maximum speed. The aim of treatment is health, not the steepest possible line on a chart.

As with everything here, individual results vary, and none of these effects is certain to happen to you. If you are worried about any of them before you start, say so in your consultation; your prescriber can talk through what to watch for.

10 · Serious effects and mood

Serious side effects, mood and when to get help

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹

Do not wait to see whether these settle, and do not try to manage them at home. Get medical help straight away, and tell staff which medicine you are taking.

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹ This is an adjustment, not a prohibition; the key is that your prescriber knows about every medicine you use.

Mood is the other topic people ask about, so it deserves a clear answer. Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

That said, any big change in weight, appetite and routine can affect how you feel — tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.¹⁷ Telling your prescriber in advance is not a barrier to treatment; it simply lets them watch for changes with you.

Reporting is part of safety too. If you experience anything unexpected, you can report a suspected side effect through the MHRA Yellow Card scheme.¹⁹ Reports help regulators spot patterns early, which benefits everyone taking these medicines.

11 · Other options compared fairly

Wegovy, tablets, liraglutide and supplements

Wegovy (semaglutide) is a different medicine with its own product information, which lists its side effects.¹⁸ Our page on Wegovy or Mounjaro and side effects goes through the comparison in more depth.

Liraglutide, sold as Saxenda and in other products, is supplied at a concentration of 6mg per millilitre and is a daily injection, unlike once-weekly Mounjaro and Wegovy. A daily schedule is a practical difference some people weigh up. Your prescriber can advise.

There are also tablets. Wegovy tablets and Foundayo (orforglipron) are oral options with their own prescribing information.²⁰²¹ A tablet may suit someone who dislikes needles, but results from separate trials should not be set against Mounjaro's as if they were head to head.

Then there are supplements marketed as natural alternatives. Be wary of anything sold as having no side effects. Low-cost supplements are available cheaply without assessment, dosing is not standardised, and they have not been shown to deliver the results of licensed medicines. Their cheapness and "natural" label say nothing about safety or effect, and there is no clinical oversight if something goes wrong. Dramatic weight-loss claims on such products are a warning sign, not a recommendation.

What about the NHS? Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. NHS access to Wegovy runs through specialist weight-management services; ask your GP.

A prescriber can look at your health history and advise which treatment suits you. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

Beware too of anyone offering to supply without a consultation or prescription. Our supply is official LillyDirect supply, with genuine KwikPens. You can check our registration, GPhC 9012878, on the public register.¹² For a wider survey, see whether Mounjaro has fewer side effects.